Formulating Cannabis with Functional Lipids for the Nutritional Market
Join us as we explore the unique challenges of solubilization, emulsification, and bioavailability in a range of CBD formulations and how lipid technologies can not only solve this challenges but bring new value and function to your products.
This LIVE event has already taken place
Fill out form below to access the recorded version of this event and receive a copy of the presentation.
Webinar Speakers
Alice D. Hirschel, PhD
Technical Business Director @ABITEC Corporation
Dr. Alice D. Hirschel has 10 years of research in disease nutrient-interactions and 9 years product and commercial development experience in the food and nutrition industry. She graduated with a BS in Nutritional Sciences from the University of Georgia and a PhD in Nutritional Sciences from the University of Texas at Austin. Dr. Hirschel began formulating supplements as a Product Development Scientist at GNC. She transitioned to Commercial Development with Innophos Nutrition and now, Dr. Hirschel works in technical, commercial and business development, learning to execute sales and marketing strategies with ABITEC Corp.
John Tillotson, R.Ph., Ph.D.
Pharmaceutical Technical Business Director @ABITEC Corporation
B.S. in Pharmacy from Ferris State University and Ph.D. in Industrial Pharmacy from the University of Cincinnati.
Dr. Tillotson’s primary areas of interest are self-emulsifying drug delivery systems (SEDDS), tableted SEDDS, lipid-based drug delivery, quick dissolve tablet technologies, directly compressible modalities, wet and dry granulation, spray-drying, and multiple-regression analysis. He was involved with the development and optimization of bumetanide sustained release technologies has formulated several quick dissolve systems for nutraceuticals, OTC products, and prescription products. He has authored patents for the development of orally-dissolving tableting and powder systems. His published papers discuss the use of multiple-response optimization and the benefits of SEDDS, lipid-based drug delivery, solid lipid nanoparticles, and various ODT excipient systems. He is a member of the Rho Chi Pharmaceutical Honor Society and of AAPS.
Questions or issues with registering for the webinar, please contact Amanda Coulter - [email protected]